Valuation : IOL Chemicals and Pharmaceuticals Limited

Market Cap 56.8B 595M 512M 485M 440M 825M 829M 5.76B 2.22B 28.9B 2.23B 2.18B 91.31B P/E 2027 *
25.8x
P/E 2028 * 19.9x
Enterprise Value 56.8B 595M 512M 485M 440M 825M 829M 5.76B 2.22B 28.9B 2.23B 2.18B 91.31B EV / Sales 2027 *
2.07x
EV / Sales 2028 * 1.8x
Free-Float
33.91%
Yield 2027 *
-
Yield 2028 * -

Last Transcript : IOL Chemicals and Pharmaceuticals Limited

1 day-8.42%
1 week-1.28%
Current month-0.15%
1 month+17.31%
3 months+49.48%
6 months+166.64%
Current year+135.26%
1 week 191.8
Extreme 191.8
219.05
1 month 155.15
Extreme 155.15
219.05
Current year 67.14
Extreme 67.14
219.05
1 year 67.14
Extreme 67.14
219.05
3 years 57.51
Extreme 57.51
219.05
5 years 54.44
Extreme 54.44
219.05
10 years 8.4
Extreme 8.4
219.05
Manager TitleAgeSince
Chief Executive Officer 34 -
Director of Finance/CFO - -
Compliance Officer - 14/11/2019
Director TitleAgeSince
Chairman 63 01/09/2007
Director/Board Member 34 29/05/2015
Chairman 73 -
Change 5-day change 1-year change 3-year change Capi.($)
-8.42%-1.28%+70.44%+99.57% 649M
-0.61%-2.95%+47.50%+87.30% 1,001B
-0.20%-3.50%+48.80%+63.29% 642B
+0.90%+0.27%+16.77%+72.54% 451B
-0.38%-3.59%+28.24%+35.57% 340B
-0.09%-13.54%+10.08%+26.87% 263B
-0.43%-2.48%-2.07%+11.48% 247B
-0.87%-13.31%+34.07%+44.83% 207B
-3.44%-7.51%-20.08%-59.58% 197B
-0.63%-4.78%+21.98%+86.62% 180B
Average -1.40%-4.19%+25.57%+46.85% 352.7B
Weighted average by Cap. -0.45%-4.65%+29.84%+55.53%

Financials

2027 *2028 *
Net sales 27.42B 287M 247M 234M 212M 398M 400M 2.78B 1.07B 13.95B 1.08B 1.05B 44.09B 31.52B 330M 284M 269M 244M 458M 460M 3.2B 1.23B 16.04B 1.24B 1.21B 50.68B
Net income 2.2B 23.01M 19.82M 18.77M 17.01M 31.92M 32.08M 223M 85.72M 1.12B 86.41M 84.51M 3.53B 2.84B 29.73M 25.61M 24.25M 21.98M 41.24M 41.45M 288M 111M 1.44B 112M 109M 4.57B
Net Debt - -
Logo IOL Chemicals and Pharmaceuticals Limited
IOL Chemicals and Pharmaceuticals Limited is engaged in manufacturing and selling of pharmaceutical and chemical products. The Company operates through two segments: Chemical and Pharmaceutical. The Chemical segment produces and sells Ethyl Acetate, Iso Butyl Benzene, Acetyl Chloride, Mono Chloro Acetic Acid, Para Amino Phenol (PAP), and others. The Pharmaceutical segment produces and sells various active pharma ingredients (API) including Ibuprofen, Metformin, Fenofibrate, Lamotrigine, Clopidogrel Bisulphate, Pantoprazole, Gabapentin, Paracetamol, and others. Its API product portfolio includes Pantoprazole Sodium, Clopidogrel Bisulphate (Form II), Losartan Potassium, Levetiracetam, and Fenofibrate (Micronised). Its Specialty Chemical division includes Ethyl Acetate, Iso Butyl Benzene, Mono Chloro acetic Acid, and Acetic Anhydride. Its Ethyl Acetate is used in industries like flexible packaging, pharmaceuticals, ink, food processing, pesticides, and the paint industry.
Employees
3,095
Date Price Change Volume
11/09/26 INR 193.50 -8.42% 523,555
10/09/26 INR 211.30 +0.74% 335,741
09/09/26 INR 209.75 -0.52% 353,418
08/09/26 INR 210.85 -1.03% 350,683
07/09/26 INR 213.05 +6.50% 709,437
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
193.50INR
Average target price
197.00INR
Spread / Average Target
+1.81%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IOLCP Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!